Looking towards the shape of things to come

Article

A recent survey looked at how doctors adopt and use new technology, including the internet and found that overall an increasing amount of their time is being spent online and access to the most up-to-date online medical and pharmaceutical resources plays and increasingly important role.

A recent survey looked at how doctors adopt and use new technology, including the internet and found that overall an increasing amount of their time is being spent online and access to the most up-to-date online medical and pharmaceutical resources plays an increasingly important role. For example, the number of doctors using smartphones shot up 64% in 2009 and doctors using mobile devices such as iPhones and BlackBerries increased by 20% between 2008 and 2009. According to Monique Levy, senior director of research at Manhattan Research (which conducted the survey): "Physicians have always been advanced in terms of their mobile use. Nevertheless, growth in smartphone ownership in the last year is remarkable. Mobile is delivering on its promise to allow doctors to be 'always on' — which is partly why so many doctors say the intenet is essential to their practice."

That has also been our experience over the past 12 months at Ophthalmology Times Europe and so with that in mind the editorial team will be introducing a brand new, innovative, twice-monthly OTE digital magazine for readers offering you a timely and content rich extension to our print magazine, enewsletter and website.

Ophthalmology Times Digest Europe means you can receive an OTE digest that will draw on all the information sources available to us and deliver them to you in a quick, easy-to-read format that will also offer you the option to download and read at your leisure. The content will be different to that offered in our print magazine and newsletter and takes account of the fact that not everyone has sufficient time to invest in reading a print magazine and we want to deliver the best possible return on the investment our readers make in us.

If you would like to guarantee you receive a copy of Ophthalmology Times Digest Europe please email your request to the editor pbrook@advanstar.com

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.